These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis. Yuan X; Cai C; Chen S; Chen S; Yu Z; Balk SP Oncogene; 2014 May; 33(22):2815-25. PubMed ID: 23752196 [TBL] [Abstract][Full Text] [Related]
3. Intratumoral androgen biosynthesis in prostate cancer pathogenesis and response to therapy. Cai C; Balk SP Endocr Relat Cancer; 2011 Oct; 18(5):R175-82. PubMed ID: 21712345 [TBL] [Abstract][Full Text] [Related]
4. Androgen receptors in hormone-dependent and castration-resistant prostate cancer. Shafi AA; Yen AE; Weigel NL Pharmacol Ther; 2013 Dec; 140(3):223-38. PubMed ID: 23859952 [TBL] [Abstract][Full Text] [Related]
5. Beyond T and DHT - novel steroid derivatives capable of wild type androgen receptor activation. Mostaghel EA Int J Biol Sci; 2014; 10(6):602-13. PubMed ID: 24948873 [TBL] [Abstract][Full Text] [Related]
6. Testosterone boosts for treatment of castration resistant prostate cancer: an experimental implementation of intermittent androgen deprivation. Thelen P; Heinrich E; Bremmer F; Trojan L; Strauss A Prostate; 2013 Nov; 73(15):1699-709. PubMed ID: 23868789 [TBL] [Abstract][Full Text] [Related]
7. Steroidogenic enzyme AKR1C3 is a novel androgen receptor-selective coactivator that promotes prostate cancer growth. Yepuru M; Wu Z; Kulkarni A; Yin F; Barrett CM; Kim J; Steiner MS; Miller DD; Dalton JT; Narayanan R Clin Cancer Res; 2013 Oct; 19(20):5613-25. PubMed ID: 23995860 [TBL] [Abstract][Full Text] [Related]
8. The expression of glucocorticoid receptor is negatively regulated by active androgen receptor signaling in prostate tumors. Xie N; Cheng H; Lin D; Liu L; Yang O; Jia L; Fazli L; Gleave ME; Wang Y; Rennie P; Dong X Int J Cancer; 2015 Feb; 136(4):E27-38. PubMed ID: 25138562 [TBL] [Abstract][Full Text] [Related]
9. Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors. Cai C; Chen S; Ng P; Bubley GJ; Nelson PS; Mostaghel EA; Marck B; Matsumoto AM; Simon NI; Wang H; Chen S; Balk SP Cancer Res; 2011 Oct; 71(20):6503-13. PubMed ID: 21868758 [TBL] [Abstract][Full Text] [Related]
10. Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways. Vis AN; Schröder FH BJU Int; 2009 Aug; 104(4):438-48. PubMed ID: 19558559 [TBL] [Abstract][Full Text] [Related]
11. Nuclear receptor ERRα contributes to castration-resistant growth of prostate cancer via its regulation of intratumoral androgen biosynthesis. Xu Z; Ma T; Zhou J; Gao W; Li Y; Yu S; Wang Y; Chan FL Theranostics; 2020; 10(9):4201-4216. PubMed ID: 32226548 [TBL] [Abstract][Full Text] [Related]
13. Effects of manganese superoxide dismutase silencing on androgen receptor function and gene regulation: implications for castration-resistant prostate cancer. Sharifi N; Hurt EM; Thomas SB; Farrar WL Clin Cancer Res; 2008 Oct; 14(19):6073-80. PubMed ID: 18829485 [TBL] [Abstract][Full Text] [Related]
14. Reactivation of androgen receptor-regulated lipid biosynthesis drives the progression of castration-resistant prostate cancer. Han W; Gao S; Barrett D; Ahmed M; Han D; Macoska JA; He HH; Cai C Oncogene; 2018 Feb; 37(6):710-721. PubMed ID: 29059155 [TBL] [Abstract][Full Text] [Related]
15. Androgen receptor: what we know and what we expect in castration-resistant prostate cancer. Cai Z; Chen W; Zhang J; Li H Int Urol Nephrol; 2018 Oct; 50(10):1753-1764. PubMed ID: 30128923 [TBL] [Abstract][Full Text] [Related]
16. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells. Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225 [TBL] [Abstract][Full Text] [Related]
17. Small molecule screening reveals a transcription-independent pro-survival function of androgen receptor in castration-resistant prostate cancer. Narizhneva NV; Tararova ND; Ryabokon P; Shyshynova I; Prokvolit A; Komarov PG; Purmal AA; Gudkov AV; Gurova KV Cell Cycle; 2009 Dec; 8(24):4155-67. PubMed ID: 19946220 [TBL] [Abstract][Full Text] [Related]
18. Castration-resistant prostate cancer: locking up the molecular escape routes. Attar RM; Takimoto CH; Gottardis MM Clin Cancer Res; 2009 May; 15(10):3251-5. PubMed ID: 19447877 [TBL] [Abstract][Full Text] [Related]
19. Oxidative stress and androgen receptor signaling in the development and progression of castration-resistant prostate cancer. Shiota M; Yokomizo A; Naito S Free Radic Biol Med; 2011 Oct; 51(7):1320-8. PubMed ID: 21820046 [TBL] [Abstract][Full Text] [Related]
20. Castration induces up-regulation of intratumoral androgen biosynthesis and androgen receptor expression in an orthotopic VCaP human prostate cancer xenograft model. Knuuttila M; Yatkin E; Kallio J; Savolainen S; Laajala TD; Aittokallio T; Oksala R; Häkkinen M; Keski-Rahkonen P; Auriola S; Poutanen M; Mäkelä S Am J Pathol; 2014 Aug; 184(8):2163-73. PubMed ID: 24949550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]